| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 3797913
[patent_doc_number] => 05827820
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-10-27
[patent_title] => 'Aqueous peritoneal dialysis solution'
[patent_app_type] => 1
[patent_app_number] => 8/884557
[patent_app_country] => US
[patent_app_date] => 1997-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3263
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 119
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/827/05827820.pdf
[firstpage_image] =>[orig_patent_app_number] => 884557
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/884557 | Aqueous peritoneal dialysis solution | Jun 26, 1997 | Issued |
Array
(
[id] => 4364527
[patent_doc_number] => 06274336
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-08-14
[patent_title] => 'Method of inhibiting cathepsin K'
[patent_app_type] => 1
[patent_app_number] => 8/860255
[patent_app_country] => US
[patent_app_date] => 1997-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 318093
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 172
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/274/06274336.pdf
[firstpage_image] =>[orig_patent_app_number] => 860255
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/860255 | Method of inhibiting cathepsin K | Jun 25, 1997 | Issued |
Array
(
[id] => 4051428
[patent_doc_number] => 05969098
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-10-19
[patent_title] => 'Yeast-toxin-related protein for antimicrobial vaccine and sterilizing preservative use'
[patent_app_type] => 1
[patent_app_number] => 8/898885
[patent_app_country] => US
[patent_app_date] => 1997-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 3284
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/969/05969098.pdf
[firstpage_image] =>[orig_patent_app_number] => 898885
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/898885 | Yeast-toxin-related protein for antimicrobial vaccine and sterilizing preservative use | Jun 5, 1997 | Issued |
Array
(
[id] => 4190069
[patent_doc_number] => 06153593
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-11-28
[patent_title] => 'Laminin 5 and the formation of basement membrane structure'
[patent_app_type] => 1
[patent_app_number] => 8/868600
[patent_app_country] => US
[patent_app_date] => 1997-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 6
[patent_no_of_words] => 2938
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/153/06153593.pdf
[firstpage_image] =>[orig_patent_app_number] => 868600
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/868600 | Laminin 5 and the formation of basement membrane structure | Jun 3, 1997 | Issued |
Array
(
[id] => 4185014
[patent_doc_number] => 06159938
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-12-12
[patent_title] => 'Serine protease inhibitors comprising .alpha.-keto heterocycles'
[patent_app_type] => 1
[patent_app_number] => 8/859242
[patent_app_country] => US
[patent_app_date] => 1997-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13622
[patent_no_of_claims] => 77
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/159/06159938.pdf
[firstpage_image] =>[orig_patent_app_number] => 859242
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/859242 | Serine protease inhibitors comprising .alpha.-keto heterocycles | May 19, 1997 | Issued |
| 08/836167 | SYNTHESIS OF PEPTIDE NUCLEIC ACIDS (PNAS) AND ANALOGUES VIA SUBMONOMER APPROACH | May 6, 1997 | Abandoned |
Array
(
[id] => 4089205
[patent_doc_number] => 06018024
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-01-25
[patent_title] => 'Methods and compositions for monitoring cellular processing of beta-amyloid precursor protein'
[patent_app_type] => 1
[patent_app_number] => 8/846444
[patent_app_country] => US
[patent_app_date] => 1997-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 8
[patent_no_of_words] => 8985
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/018/06018024.pdf
[firstpage_image] =>[orig_patent_app_number] => 846444
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/846444 | Methods and compositions for monitoring cellular processing of beta-amyloid precursor protein | Apr 30, 1997 | Issued |
Array
(
[id] => 4005885
[patent_doc_number] => 05859184
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-01-12
[patent_title] => 'Alpha-helix mimetics and methods relating thereto'
[patent_app_type] => 1
[patent_app_number] => 8/846431
[patent_app_country] => US
[patent_app_date] => 1997-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 5518
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/859/05859184.pdf
[firstpage_image] =>[orig_patent_app_number] => 846431
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/846431 | Alpha-helix mimetics and methods relating thereto | Apr 29, 1997 | Issued |
Array
(
[id] => 3929406
[patent_doc_number] => 05877276
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-03-02
[patent_title] => 'Polypeptide agonists for human interleukin-8'
[patent_app_type] => 1
[patent_app_number] => 8/847696
[patent_app_country] => US
[patent_app_date] => 1997-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 13
[patent_no_of_words] => 11248
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 248
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/877/05877276.pdf
[firstpage_image] =>[orig_patent_app_number] => 847696
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/847696 | Polypeptide agonists for human interleukin-8 | Apr 27, 1997 | Issued |
| 08/842462 | INTERFERON CONJUGATES | Apr 23, 1997 | Abandoned |
Array
(
[id] => 4112540
[patent_doc_number] => 06071510
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-06-06
[patent_title] => 'Modified amino acids and compositions comprising the same for delivering active agents'
[patent_app_type] => 1
[patent_app_number] => 8/839094
[patent_app_country] => US
[patent_app_date] => 1997-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7600
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/071/06071510.pdf
[firstpage_image] =>[orig_patent_app_number] => 839094
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/839094 | Modified amino acids and compositions comprising the same for delivering active agents | Apr 22, 1997 | Issued |
Array
(
[id] => 4192542
[patent_doc_number] => 06043216
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-03-28
[patent_title] => 'Methods and composition for detecting and treating kidney diseases associated with adhesion of crystals to kidney cells'
[patent_app_type] => 1
[patent_app_number] => 8/837226
[patent_app_country] => US
[patent_app_date] => 1997-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 9
[patent_no_of_words] => 23550
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/043/06043216.pdf
[firstpage_image] =>[orig_patent_app_number] => 837226
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/837226 | Methods and composition for detecting and treating kidney diseases associated with adhesion of crystals to kidney cells | Apr 9, 1997 | Issued |
Array
(
[id] => 3772427
[patent_doc_number] => 05807826
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-09-15
[patent_title] => 'Semaphorin gene family'
[patent_app_type] => 1
[patent_app_number] => 8/835268
[patent_app_country] => US
[patent_app_date] => 1997-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22842
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 119
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/807/05807826.pdf
[firstpage_image] =>[orig_patent_app_number] => 835268
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/835268 | Semaphorin gene family | Apr 7, 1997 | Issued |
Array
(
[id] => 3978278
[patent_doc_number] => 05905141
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-05-18
[patent_title] => 'Ultra pure hemoglobin solutions and blood substitutes'
[patent_app_type] => 1
[patent_app_number] => 8/838514
[patent_app_country] => US
[patent_app_date] => 1997-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 36
[patent_no_of_words] => 35719
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/905/05905141.pdf
[firstpage_image] =>[orig_patent_app_number] => 838514
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/838514 | Ultra pure hemoglobin solutions and blood substitutes | Apr 7, 1997 | Issued |
Array
(
[id] => 3885768
[patent_doc_number] => 05776897
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-07-07
[patent_title] => 'Treating disorders by application of insulin-like growth factors and analogs'
[patent_app_type] => 1
[patent_app_number] => 8/823245
[patent_app_country] => US
[patent_app_date] => 1997-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 23
[patent_no_of_words] => 21437
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/776/05776897.pdf
[firstpage_image] =>[orig_patent_app_number] => 823245
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/823245 | Treating disorders by application of insulin-like growth factors and analogs | Mar 23, 1997 | Issued |
Array
(
[id] => 4089033
[patent_doc_number] => 06133236
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-10-17
[patent_title] => 'Products and methods for improving keratinocyte adhesion to the dermis'
[patent_app_type] => 1
[patent_app_number] => 8/815886
[patent_app_country] => US
[patent_app_date] => 1997-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 15
[patent_no_of_words] => 17388
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/133/06133236.pdf
[firstpage_image] =>[orig_patent_app_number] => 815886
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/815886 | Products and methods for improving keratinocyte adhesion to the dermis | Mar 11, 1997 | Issued |
| 90/004576 | PROTEIN FRAGMENTS CONTAINING FACTOR VIII BINDING DOMAIN OF VON WILLEBRAND FACTOR | Mar 6, 1997 | Issued |
| 90/004577 | FACTOR VIII BINDING DOMAIN OF VON WILLEBRAND FACTOR | Mar 6, 1997 | Issued |
Array
(
[id] => 3951719
[patent_doc_number] => 05955574
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-09-21
[patent_title] => 'Analogs of parathyroid hormone'
[patent_app_type] => 1
[patent_app_number] => 8/813534
[patent_app_country] => US
[patent_app_date] => 1997-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7453
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 376
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/955/05955574.pdf
[firstpage_image] =>[orig_patent_app_number] => 813534
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/813534 | Analogs of parathyroid hormone | Mar 6, 1997 | Issued |
Array
(
[id] => 3995298
[patent_doc_number] => 05985826
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-11-16
[patent_title] => 'Methods of using hepatic-directed compounds in pretargeting strategies'
[patent_app_type] => 1
[patent_app_number] => 8/808024
[patent_app_country] => US
[patent_app_date] => 1997-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 23557
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/985/05985826.pdf
[firstpage_image] =>[orig_patent_app_number] => 808024
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/808024 | Methods of using hepatic-directed compounds in pretargeting strategies | Mar 2, 1997 | Issued |